DROPERIDOL; FENTANYL CITRATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for droperidol; fentanyl citrate and what is the scope of patent protection?
Droperidol; fentanyl citrate
is the generic ingredient in two branded drugs marketed by Astrazeneca, Hospira, and Epic Pharma Llc, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.Summary for DROPERIDOL; FENTANYL CITRATE
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 3 |
NDAs: | 5 |
DailyMed Link: | DROPERIDOL; FENTANYL CITRATE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for DROPERIDOL; FENTANYL CITRATE
US Patents and Regulatory Information for DROPERIDOL; FENTANYL CITRATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epic Pharma Llc | INNOVAR | droperidol; fentanyl citrate | INJECTABLE;INJECTION | 016049-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Astrazeneca | FENTANYL CITRATE AND DROPERIDOL | droperidol; fentanyl citrate | INJECTABLE;INJECTION | 072027-001 | Apr 13, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Astrazeneca | FENTANYL CITRATE AND DROPERIDOL | droperidol; fentanyl citrate | INJECTABLE;INJECTION | 072028-001 | Apr 13, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Astrazeneca | FENTANYL CITRATE AND DROPERIDOL | droperidol; fentanyl citrate | INJECTABLE;INJECTION | 072026-001 | Apr 13, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hospira | FENTANYL CITRATE AND DROPERIDOL | droperidol; fentanyl citrate | INJECTABLE;INJECTION | 071982-001 | May 4, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |